Molecular mechanisms of drug-induced thrombocytopenia

被引:15
作者
Burgess, JK [1 ]
机构
[1] Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia
关键词
D O I
10.1097/00062752-200109000-00005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A wide range of drugs can induce thrombocytopenia. Molecular mechanisms for the formation of specific epitopes for all the drug-dependent antibodies appear to be very similar A restricted set of glycoproteins an the platelet surface interacts with the drugs to form neoepitopes, to which the drug-dependent antibodies bind. Molecular mapping of antigenic sites may help characterize genetic polymorphisms that predispose to the formation of the antibody binding sites. Identification of antibody binding sites will enhance our understanding of the pathogenesis of immune drug-induced thrombocytopenia. Curr Opin Hematol 2001, 8:294-298 (C) 2001 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:294 / 298
页数:5
相关论文
共 40 条
  • [31] Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patients
    Polgár, J
    Eichler, P
    Greinacher, A
    Clemetson, KJ
    [J]. BLOOD, 1998, 91 (02) : 549 - 554
  • [32] 7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1
    Simon, DI
    Xu, H
    Ortlepp, S
    Rogers, C
    Rao, NK
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (03) : 528 - 535
  • [33] Antibodies from patients with heparin-induced thrombocytopenia/thrombosis recognize different epitopes on heparin: Platelet factor 4
    Suh, JS
    Aster, RH
    Visentin, GP
    [J]. BLOOD, 1998, 91 (03) : 916 - 922
  • [34] PHARMACODYNAMICS OF CHIMERIC GLYCOPROTEIN IIB/IIIA INTEGRIN ANTIPLATELET ANTIBODY FAB 7E3 IN HIGH-RISK CORONARY ANGIOPLASTY
    TCHENG, JE
    ELLIS, SG
    GEORGE, BS
    KEREIAKES, DJ
    KLEIMAN, NS
    TALLEY, JD
    WANG, AL
    WEISMAN, HF
    CALIFF, RM
    TOPOL, EJ
    [J]. CIRCULATION, 1994, 90 (04) : 1757 - 1764
  • [35] Platelet GPIIb-IIIa blockers
    Topol, EJ
    Byzova, TV
    Plow, EF
    [J]. LANCET, 1999, 353 (9148) : 227 - 231
  • [36] VISENTIN GP, 1991, BLOOD, V77, P2668
  • [37] Visentin GP, 1999, THROMB HAEMOSTASIS, V82, P448
  • [38] ANTIBODIES FROM PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA/THROMBOSIS ARE SPECIFIC FOR PLATELET FACTOR-4 COMPLEXED WITH HEPARIN OR BOUND TO ENDOTHELIAL-CELLS
    VISENTIN, GP
    FORD, SE
    SCOTT, JP
    ASTER, RH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (01) : 81 - 88
  • [39] Laboratory investigation of immune thrombocytopenia
    Warner, M
    Kelton, JG
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (01) : 5 - 12
  • [40] Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia
    Ziporen, L
    Li, ZQ
    Park, KS
    Sabnekar, P
    Liu, WY
    Arepally, G
    Shoenfeld, Y
    Kieber-Emmons, T
    Cines, DB
    Poncz, M
    [J]. BLOOD, 1998, 92 (09) : 3250 - 3259